Related Experiment Video
Updated: Dec 23, 2025

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.1K
Link Prediction Only With Interaction Data and its Application on Drug Repositioning.
IEEE Transactions on Nanobioscience
|April 29, 2020
Summary
This study introduces a new computational method using network interactions to predict drug-disease associations, improving drug development. The approach effectively identifies potential treatments even with incomplete data and noisy negative samples.
Area of Science:
- Computational biology
- Pharmacology
- Bioinformatics
Background:
- Computational methods aid drug development by predicting drug-disease associations.
- Existing methods struggle with incomplete feature data and unreliable negative samples.
Purpose of the Study:
- To propose a novel method (TS-SVD) for predicting drug-disease associations using network interactions.
- To address limitations of existing methods concerning data completeness and negative sample selection.
Main Methods:
- Constructed a drug-protein-disease heterogeneous network.
- Calculated topological similarity using common neighbors.
- Generated low-dimensional embeddings via topological features and Singular Value Decomposition (SVD).
- Employed a Random Forest classifier with carefully selected negative samples.
Main Results:
- Achieved better or comparable performance than state-of-the-art methods using less information.
- Demonstrated improved prediction accuracy through a novel negative sample selection strategy.
- Case studies confirmed the method's practicality for discovering novel associations.
Conclusions:
- The TS-SVD method offers a robust approach for predicting drug-disease associations.
- The negative sample selection strategy enhances model reliability and performance.
- This method facilitates efficient drug discovery and development.
Related Concept Videos
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Drug-Receptor Interactions
7.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K
Quantitative Aspects of Drug-Receptor Interaction
1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Ligand Binding Sites
14.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.7K

